These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29701586)

  • 1. How RWE Is Becoming the Real Deal.
    Reinke T
    Manag Care; 2018 Apr; 27(4):30-32. PubMed ID: 29701586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-World Evidence in the Real World: Beyond the FDA.
    Krause JH; Saver RS
    Am J Law Med; 2018 May; 44(2-3):161-179. PubMed ID: 30106647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New FDA Real-World Evidence Program to Support Development of Drugs and Biologics.
    Klonoff DC
    J Diabetes Sci Technol; 2020 Mar; 14(2):345-349. PubMed ID: 30862182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonrandomized Real-World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
    Franklin JM; Pawar A; Martin D; Glynn RJ; Levenson M; Temple R; Schneeweiss S
    Clin Pharmacol Ther; 2020 Apr; 107(4):817-826. PubMed ID: 31541454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining the Use of Real-World Evidence in the Regulatory Process.
    Beaulieu-Jones BK; Finlayson SG; Yuan W; Altman RB; Kohane IS; Prasad V; Yu KH
    Clin Pharmacol Ther; 2020 Apr; 107(4):843-852. PubMed ID: 31562770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of real-world data/evidence in regulatory submissions.
    Song F; Zang C; Ma X; Hu S; Sun Q; Chow SC; Sun H
    Contemp Clin Trials; 2021 Oct; 109():106521. PubMed ID: 34339865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated Plans Fertile For Real-world Evidence.
    Diamond F
    Manag Care; 2017 Jan; 26(1):27-28. PubMed ID: 28121595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New office and new leader aim to streamline FDA cancer drug review process.
    Twombly R
    J Natl Cancer Inst; 2005 May; 97(10):708-9. PubMed ID: 15900036
    [No Abstract]   [Full Text] [Related]  

  • 9. Timing and Characteristics of Cumulative Evidence Available on Novel Therapeutic Agents Receiving Food and Drug Administration Accelerated Approval.
    Naci H; Wouters OJ; Gupta R; Ioannidis JPA
    Milbank Q; 2017 Jun; 95(2):261-290. PubMed ID: 28589600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FDA, Gottlieb Get Real About Real-world evidence.
    Kirkner RM
    Manag Care; 2019 Mar; 28(3):13-16. PubMed ID: 30883304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Evidence Faces Some Real-World Challenges.
    Reinke T
    Manag Care; 2017 May; 26(5):35-36. PubMed ID: 28661852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Statistical Roadmap for Journey from Real-World Data to Real-World Evidence.
    Fang Y; Wang H; He W
    Ther Innov Regul Sci; 2020 Jul; 54(4):749-757. PubMed ID: 32557297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Clinical Trial or Real-World Evidence: How Historical Events, Public Demand, and the Resulting Laws and Regulations Shaped the Body of Medical Evidence.
    Mackowiak JI; Mack CD; Irwin DE; Zura R
    J Orthop Trauma; 2021 Mar; 35(Suppl 1):S17-S21. PubMed ID: 33587542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-World Evidence Utilization in Clinical Development Reflected by US Product Labeling: Statistical Review.
    Seifu Y; Gamalo-Siebers M; Barthel FM; Lin J; Qiu J; Cooner F; Ruan S; Walley R
    Ther Innov Regul Sci; 2020 Nov; 54(6):1436-1443. PubMed ID: 32514737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA begins product approval initiative.
    Lewis C
    FDA Consum; 2003; 37(3):10-1. PubMed ID: 12793386
    [No Abstract]   [Full Text] [Related]  

  • 16. Report on the current status of the use of real-world data (RWD) and real-world evidence (RWE) in drug development and regulation.
    Breckenridge AM; Breckenridge RA; Peck CC
    Br J Clin Pharmacol; 2019 Sep; 85(9):1874-1877. PubMed ID: 31290181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical innovation and research.
    Gates GA
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1352-3; author reply 1354. PubMed ID: 14676173
    [No Abstract]   [Full Text] [Related]  

  • 18. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
    Kulynych J
    Food Drug Law J; 1999; 54(1):127-49. PubMed ID: 11758555
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA plan for statutory compliance. Notice of availability.
    Fed Regist; 1998 Nov; 63(226):65000-40. PubMed ID: 10338873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pessimistic response to FDA leadership change.
    Kling J
    Nat Biotechnol; 2005 Nov; 23(11):1325. PubMed ID: 16273044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.